Latest Cost Reduction News

Li-S Energy narrows its loss to $1.21 million in H1 2026, propelled by a $7.8 million ARENA grant and key manufacturing milestones including Australia’s first lithium metal foil production line. Strategic defence and aerospace partnerships bolster its commercialisation drive.

Adrad Holdings reported a modest revenue rise and a dip in statutory profit for the half-year ending December 2025, while its Heat Transfer Solutions segment showed robust growth. The company declared a fully franked interim dividend, reflecting confidence amid ongoing restructuring.

APA Group has reported robust half-year results, boosting its organic growth pipeline to nearly $3 billion and reaffirming its full-year guidance amid ongoing cost reductions and strategic divestments.

IGO Limited reports a marked improvement in its half-year results, narrowing losses and boosting cash flow amid operational challenges and strategic asset sales.

Elevra Lithium reported solid Q2 FY26 production and revenue results while progressing its North American Lithium brownfield expansion and forging strategic supply partnerships.

MGX Resources reported a $20.8 million half-year loss, driven by a major rockfall at Koolan Island that halted mining and triggered a $60 million asset impairment. The company is pivoting towards gold with its recent acquisition of a 50% stake in the Central Tanami Project.

Telstra Group Limited reported solid half-year results for December 2025, with revenue and profit growth underpinning a higher dividend and an expanded share buy-back program. The company’s Connected Future 30 strategy continues to drive operational momentum amid disciplined cost management.

Healius Limited reported solid half-year results for 1H26, with revenue growth driven by pathology and Agilex Biolabs, alongside significant progress in digital transformation and AI integration.

Spark New Zealand’s H1 FY26 results reveal a strong rebound in profitability driven by mobile service revenue growth and disciplined cost reductions, alongside the strategic sale of its data centre business.

Botanix Pharmaceuticals has launched a A$45 million capital raising to support the expansion of its dermatology product Sofdra®, while negotiating to reduce active pharmaceutical ingredient costs by up to 40%. The raising includes a two-tranche placement and a security purchase plan, with options offered to investors.

Botanix Pharmaceuticals has secured approximately A$45 million through a two-tranche placement and an underwritten security purchase plan to fund API purchases, derisk its supply chain, and accelerate growth of its flagship product Sofdra.

Centaurus Metals has successfully produced over half a tonne of high-grade direct reduction pellet feed from its Jambreiro Iron Ore Project, confirming the product's quality and advancing off-take discussions.